問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Cardiovascular Diseases

Division of General Internal Medicine

更新時間:2023-09-19

吳卓鍇WU, CHO-KAI
  • Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

Publication

23Publications

21

Wang, T. D., Lee, Y. H., Chang, S. S., Tung, Y. C., Yeh, C. F., Lin, Y. H., Pan, C. T., Hsu, C. Y., Huang, C. Y., Wu, C. K., Sung, P. H., Chiang, L. T., Wang, Y. C., Tsai, W. C., Lin, T. T., Lin, C. P., Chen, W. J., & Hwang, J. J. (2019). 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Acta Cardiologica Sinica, 35(3), 199-230. https://doi.org/10.6515/acs.201905_35(3).20190415a

22

Wu, C. K., Cheng, J. F., Huang, C. Y., Chen, Z. W., Chen, S. Y., & Lin, L. Y. (2021). Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction-the ILO-HOPE randomised controlled trial. British Journal of Clinical Pharmacology, 87(3), 1165-1174. https://doi.org/10.1111/bcp.14484

23

Wu, C. K., Lee, J. K., Hsu, J. C., Su, M. Y. M., Wu, Y. F., Lin, T. T., Lan, C. W., Hwang, J. J., & Lin, L. Y. (2020). Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. European Journal of Heart Failure, 22(3), 445-454. https://doi.org/10.1002/ejhf.1617
1 2 3